References
1. Jersoviene V, Gudleviciene Z,
Rimiene J, Butkauskas D. Human Papillomavirus and Infertility. Medicina.
2019;55(7).
2. Souho T, Benlemlih M, Bennani B.
Human papillomavirus infection and fertility alteration: a systematic
review. PloS one. 2015;10(5):e0126936.
3. Xiong YQ, Chen YX, Cheng MJ, He WQ,
Chen Q. The risk of human papillomavirus infection for male fertility
abnormality: a meta-analysis. Asian journal of andrology.
2018;20(5):493-7.
4. Lewitowicz P, Nasierowska-Guttmejer
A, Rokita W, Adamczyk-Gruszka O, Gluszek S, Chrapek M, et al. HPV
genotyping and p16/Ki-67 test significantly improve detection rate of
high-grade cervical squamous intraepithelial lesion. Archives of Medical
Science: AMS. 2020;16(1):87.
5. Kousha A MA, Maleki A, Najmi M,
Dini M, Arjmandpour M. Package of Essential Non-communicable (PEN)
disease interventions for primary health care in lran ”IRAPEN”. Tehran:
Mojassameh; 2017. 56 p.
6. Bruni L B-RL, Albero G, Serrano B,
Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé, S. ICO Information
Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus
and Related Diseases in Iran. 2017.
7. Perrin KK, Daley EM, Naoom SF,
Packing-Ebuen JL, Rayko HL, McFarlane M, et al. Women’s reactions to HPV
diagnosis: insights from in-depth interviews. Women & health.
2006;43(2):93-110.
8. Lin H, Jeng C-J, Wang L-R.
Psychological responses of women infected with cervical human
papillomavirus: a qualitative study in Taiwan. Taiwanese Journal of
Obstetrics and Gynecology. 2011;50(2):154-8.
9. McRae J, Martin C, O’Leary J, Sharp
L. ”If you can’t treat HPV, why test for it?” Women’s attitudes to the
changing face of cervical cancer prevention: a focus group study. BMC
women’s health. 2014;14:64.
10. Daley EM, Perrin KM, McDermott
RJ, Vamos CA, Rayko HL, Packing-Ebuen JL, et al. The psychosocial burden
of HPV: a mixed-method study of knowledge, attitudes and behaviors among
HPV+ women. Journal of health psychology. 2010;15(2):279-90.
11. McCaffery K, Waller J, Nazroo J,
Wardle J. Social and psychological impact of HPV testing in cervical
screening: a qualitative study. Sexually transmitted infections.
2006;82(2):169-74.
12. Kosenko KA, Hurley RJ, Harvey JA.
Sources of the uncertainty experienced by women with HPV. Qual Health
Res. 2012;22(4):534-45.
13. Waller J, McCaffery K, Kitchener
H, Nazroo J, Wardle J. Women’s experiences of repeated HPV testing in
the context of cervical cancer screening: a qualitative study.
Psychooncology. 2007;16(3):196-204.
14. Pourmohsen M, Simbar M, Nahidi F,
Fakor F, Majd HA. Women’s Experiences of Infection With Human
Papillomavirus in the Face of Disease Symptoms: A Qualitative Study.
15. Hsieh H-F, Shannon SE. Three
approaches to qualitative content analysis. Qualitative health research.
2005;15(9):1277-88.
16. Burnard P, Gill P, Stewart K,
Treasure E, Chadwick B. Analysing and presenting qualitative data.
British dental journal. 2008;204(8):429.
17. Polit DF, Beck CT. Nursing
research: Generating and assessing evidence for nursing practice:
Lippincott Williams & Wilkins; 2008.
18. Lincoln YS, Guba EG. But is it
rigorous? Trustworthiness and authenticity in naturalistic evaluation.
New directions for program evaluation. 1986;1986(30):73-84.
19. Tong A, Sainsbury P, Craig J.
Consolidated criteria for reporting qualitative research (COREQ): a
32-item checklist for interviews and focus groups. International journal
for quality in health care. 2007;19(6):349-57.
20. Depuydt CE, Donders G, Verstraete
L, Vanden Broeck D, Beert J, Salembier G, et al. Time has come to
include Human Papillomavirus (HPV) testing in sperm donor banks. Facts,
views & vision in ObGyn. 2018;10(4):201-5.
21. Capra G, Schillaci R, Bosco L,
Roccheri MC, Perino A, Ragusa MA. HPV infection in semen: results from a
new molecular approach. 2019;147:e177.
22. Graziottin A, Serafini A. HPV
infection in women: psychosexual impact of genital warts and
intraepithelial lesions. J Sex Med. 2009;6(3):633-45.
23. McCaffery K, Waller J, Nazroo J,
Wardle J. Social and psychological impact of HPV testing in cervical
screening: a qualitative study. Sexually transmitted infections.
2006;82(2):169-74.
24. Lin H, Jeng CJ, Wang LR.
Psychological responses of women infected with cervical human
papillomavirus: a qualitative study in Taiwan. Taiwanese journal of
obstetrics & gynecology. 2011;50(2):154-8.
25. Merckx M, Liesbeth W-VW, Arbyn M,
Meys J, Weyers S, Temmerman M, et al. Transmission of carcinogenic human
papillomavirus types from mother to child: a meta-analysis of published
studies. Eur J Cancer Prev. 2013;22(3):277-85.
26. Nøhr B, Kjaer SK, Soylu L, Jensen
A. High-risk human papillomavirus infection in female and subsequent
risk of infertility: a population-based cohort study. Fertility and
sterility. 2019;111(6):1236-42.
27. Zacharis K, Messini CI. Human
Papilloma Virus (HPV) and Fertilization: A Mini Review. 2018;54(4).
28. Ambühl LM, Baandrup U, Dybkær K,
Blaakær J, Uldbjerg N, Sørensen S. Human Papillomavirus Infection as a
Possible Cause of Spontaneous Abortion and Spontaneous Preterm Delivery.
Infectious diseases in obstetrics and gynecology. 2016;2016:3086036.
29. Perino A, Giovannelli L,
Schillaci R, Ruvolo G, Fiorentino FP, Alimondi P, et al. Human
papillomavirus infection in couples undergoing in vitro fertilization
procedures: impact on reproductive outcomes. Fertility and sterility.
2011;95(5):1845-8.
30. Spandorfer SD, Bongiovanni AM,
Fasioulotis S, Rosenwaks Z, Ledger WJ, Witkin SS. Prevalence of cervical
human papillomavirus in women undergoing in vitro fertilization and
association with outcome. Fertility and sterility. 2006;86(3):765-7.
31. who.int. Human papilloma virus
vaccines and infertility
WHO Weekly Epidemiological Record of 24 January 2020; 2019 [cited 2020
July]. Extract from GACVS meeting of 4-5 December 2019]. Available
from:
https://www.who.int/vaccine_safety/committee/topics/hpv/Dec_2019/en/.
32. Kyrgiou M, Mitra A, Arbyn M,
Paraskevaidi M, Athanasiou A, Martin-Hirsch PP, et al. Fertility and
early pregnancy outcomes after conservative treatment for cervical
intraepithelial neoplasia. The Cochrane database of systematic reviews.
2015;2015(9):Cd008478.
33. Daley EM, Marhefka SL, Buhi ER,
Vamos CA, Hernandez ND, Giuliano AR. Human papillomavirus vaccine
intentions among men participating in a human papillomavirus natural
history study versus a comparison sample. Sexually transmitted diseases.
2010;37(10):644-52.
34. Sun L, Herkanaidu PK, Mohur P,
Ramudoo J. Effect of pregnancy on HPV infection and on its mode of
management. Med J Obstet Gynecol. 2017;5(2):1099.
35. Bonde U, Joergensen JS, Lamont
RF, Mogensen O. Is HPV vaccination in pregnancy safe? Human vaccines &
immunotherapeutics. 2016;12(8):1960-4.
36. Tan J, Xiong YQ, He Q, Liu YM,
Wang W, Chen M, et al. Peri-conceptional or pregnancy exposure of HPV
vaccination and the risk of spontaneous abortion: a systematic review
and meta-analysis. 2019;19(1):302.
37. Nohr B, Kjaer SK, Soylu L, Jensen
A. High-risk human papillomavirus infection in female and subsequent
risk of infertility: a population-based cohort study. Fertility and
sterility. 2019;111(6):1236-42.
38. Andía D, Mozo de Rosales F,
Villasante A, Rivero B, Díez J, Pérez C. Pregnancy outcome in patients
treated with cervical conization for cervical intraepithelial neoplasia.
International Journal of Gynecology & Obstetrics. 2011;112(3):225-8.
39. Ehsanipoor RM, Jolley JA,
Goldshore MA, Szymanski LM, Haydon ML, Gaffaney CL, et al. The
relationship between previous treatment for cervical dysplasia and
preterm delivery in twin gestations. The journal of maternal-fetal &
neonatal medicine : the official journal of the European Association of
Perinatal Medicine, the Federation of Asia and Oceania Perinatal
Societies, the International Society of Perinatal Obstet.
2014;27(8):821-4.
40. Tseng CJ, Liang CC, Soong YK, Pao
CC. Perinatal transmission of human papillomavirus in infants:
relationship between infection rate and mode of delivery. Obstetrics and
gynecology. 1998;91(1):92-6.
41. Savoca S, Nardo LG, Rosano TF,
D’Agosta S, Nardo F. CO(2) laser vaporization as primary therapy for
human papillomavirus lesions. A prospective observational study. Acta
obstetricia et gynecologica Scandinavica. 2001;80(12):1121-4.
42. Skoczyński M, Goździcka-Józefiak
A, Kwaśniewska A. Co-occurrence of human papillomavirus (HPV) in
newborns and their parents. BMC infectious diseases. 2019;19(1):930.
43. Pradhan SR, Mahata S, Ghosh D,
Sahoo PK, Sarkar S, Pal R, et al. Human Papilloma Virus Infections in
Pregnant Women and Its Impact on Pregnancy Outcomes: Possible Mechanism
of Self-Clearance. Human Papillomavirus: IntechOpen; 2020.
44. Volpato LK, Siqueira IR, Nunes
RD, Piovezan AP. Association between Hormonal Contraception and Injuries
Induced by Human Papillomavirus in the Uterine Cervix. Revista
brasileira de ginecologia e obstetricia : revista da Federacao
Brasileira das Sociedades de Ginecologia e Obstetricia.
2018;40(4):196-202.